Einhorn's Greenlight Enters Obamacare-Battered Cigna (CI) and Coventry Health (CVH)
Tweet
Share
E-mailGet Alerts CI Hot Sheet
Price: $270.73 -0.73%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.3%
Revenue Growth %: +4.3%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.3%
Revenue Growth %: +4.3%
Join SI Premium – FREE
In his second quarter letter to Greenlight Capital clients, David Einhorn disclosed the fund has established several new positions in the managed care sector, including Cigna (NYSE: CI) and Coventry Health (NYSE: CVH).
Einhorn notes the entire sector has been battered in anticipation of Obamacare and these companies have unlevered balances sheets and trade at single-digit P/E multiples with growing earnings. They also have no exposure to the European crises, a China slowdown or other cyclical headline. In addition to being just plain cheap, "there is additional unpriced upside in the possibility that the election changes the political landscape, resulting in a possible modification or repeal of Obamacare," Einhorn said.
On Cigna, Einhorn said the stock deserves a higher multiple "because the plan administration business is a service business that doesn't take risk, and the other divisions do not warrant discounted values." The fund entered CI at an average price of $45.42.
On Coventry Health, Einhorn said the issues related to the Kentucky contract are "manageable and finite." He sees the company returning to breakeven or a profit on the contract in 2013. The fund's average price on CVH is $31.22.
Einhorn notes the entire sector has been battered in anticipation of Obamacare and these companies have unlevered balances sheets and trade at single-digit P/E multiples with growing earnings. They also have no exposure to the European crises, a China slowdown or other cyclical headline. In addition to being just plain cheap, "there is additional unpriced upside in the possibility that the election changes the political landscape, resulting in a possible modification or repeal of Obamacare," Einhorn said.
On Cigna, Einhorn said the stock deserves a higher multiple "because the plan administration business is a service business that doesn't take risk, and the other divisions do not warrant discounted values." The fund entered CI at an average price of $45.42.
On Coventry Health, Einhorn said the issues related to the Kentucky contract are "manageable and finite." He sees the company returning to breakeven or a profit on the contract in 2013. The fund's average price on CVH is $31.22.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Are we witnessing a fundamental or speculative rally in the S&P 500?
- Fairfax prices $750 million senior notes offering at 6.200% interest
- Amtech Systems closes $60 million public stock offering
Create E-mail Alert Related Categories
Hedge FundsRelated Entities
Greenlight Capital, David Einhorn, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
